Attached files
file | filename |
---|---|
EX-31.2 - EX-31.2 - AKCEA THERAPEUTICS, INC. | akca-ex312_9.htm |
EX-32.1 - EX-32.1 - AKCEA THERAPEUTICS, INC. | akca-ex321_10.htm |
10-K - 10-K - AKCEA THERAPEUTICS, INC. | akca-10k_20191231.htm |
EX-31.1 - EX-31.1 - AKCEA THERAPEUTICS, INC. | akca-ex311_8.htm |
EX-10.4 - EX-10.4 - AKCEA THERAPEUTICS, INC. | akca-ex104_278.htm |
EX-23.1 - EX-23.1 - AKCEA THERAPEUTICS, INC. | akca-ex231_11.htm |
EX-4.5 - EX-4.5 - AKCEA THERAPEUTICS, INC. | akca-ex45_490.htm |
EX-10.15 - EX-10.15 - AKCEA THERAPEUTICS, INC. | akca-ex1015_357.htm |
Exhibit 21.1
LIST OF SUBSIDIARIES
Akcea Therapeutics UK Limited, a United Kingdom Limited Private Company
Akcea Therapeutics Canada, Inc., a Canadian Corporation
Akcea Therapeutics France SAS, a French Company
Akcea Therapeutics Germany GmbH, a German Corporation
Akcea Therapeutics Securities Corporation, a Massachusetts Corporation
Akcea Therapeutics Ireland Limited, an Irish Private Company
Akcea Therapeutics Portugal, Unipessoal Lda, a Portuguese Company
Akcea Therapeutics Spain SL, a Spanish Company
Akcea Therapeutics Italia SRL, an Italian Company